Literature DB >> 24587644

Role of imaging in predicting response to neoadjuvant chemotherapy in gastric cancer.

Robert Michael Kwee1, Thomas Christian Kwee1.   

Abstract

With the proven overall benefit of neoadjuvant chemotherapy in patients with locally advanced gastric cancer, there has come a need to discriminate responders from non-responders. In this article, the current role of anatomical and molecular imaging in the prediction of response to neoadjuvant therapy in gastric cancer is outlined and future prospects are discussed.

Entities:  

Keywords:  Chemotherapy; Gastric cancer; Imaging; Neoadjuvant therapy; Response

Mesh：

Substances：

Year:  2014        PMID： 24587644      PMCID： PMC3930965          DOI： 10.3748/wjg.v20.i7.1650

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  38 in total

1.  [18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer.

Authors:  D Vallböhmer; A H Hölscher; P M Schneider; M Schmidt; M Dietlein; E Bollschweiler; S Baldus; H Alakus; J Brabender; R Metzger; S P Mönig
Journal:  J Surg Oncol       Date:  2010-08-01       Impact factor: 3.454

2.  Validity of response assessment criteria in neoadjuvant chemotherapy for gastric cancer (JCOG0507-A).

Authors:  Yukinori Kurokawa; Taro Shibata; Mitsuru Sasako; Takeshi Sano; Akira Tsuburaya; Yoshiaki Iwasaki; Haruhiko Fukuda
Journal:  Gastric Cancer       Date:  2013-09-03       Impact factor: 7.370

3.  Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer.

Authors:  Sook Ryun Park; Jong Seok Lee; Chan Gyoo Kim; Hark Kyun Kim; Myeong-Cherl Kook; Young-Woo Kim; Keun Won Ryu; Jun Ho Lee; Jae-Moon Bae; Il Ju Choi
Journal:  Cancer       Date:  2008-06       Impact factor: 6.860

Review 4.  Predicting and monitoring cancer treatment response with diffusion-weighted MRI.

Authors:  Harriet C Thoeny; Brian D Ross
Journal:  J Magn Reson Imaging       Date:  2010-07       Impact factor: 4.813

5.  Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy.

Authors:  Karen Becker; James D Mueller; Christoph Schulmacher; Katja Ott; Ulrich Fink; Raymonde Busch; Knut Böttcher; J Rüdiger Siewert; Heinz Höfler
Journal:  Cancer       Date:  2003-10-01       Impact factor: 6.860

6.  Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial.

Authors:  Katja Ott; Ulrich Fink; Karen Becker; Alexander Stahl; Hans-Joachim Dittler; Raymonde Busch; Hubert Stein; Florian Lordick; Thomas Link; Markus Schwaiger; Jörg-Rüdiger Siewert; Wolfgang A Weber
Journal:  J Clin Oncol       Date:  2003-12-15       Impact factor: 44.544

Review 7.  Biomarkers of response to therapy in oesophago-gastric cancer.

Authors:  K R Fareed; P Kaye; I N Soomro; M Ilyas; S Martin; S L Parsons; S Madhusudan
Journal:  Gut       Date:  2009-01       Impact factor: 23.059

8.  FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings.

Authors:  Alexander Stahl; Katja Ott; Wolfgang Andreas Weber; Karen Becker; Thomas Link; Jörg-Rüdiger Siewert; Markus Schwaiger; Ulrich Fink
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-11-08       Impact factor: 9.236

9.  Usefulness of CT volumetry for primary gastric lesions in predicting pathologic response to neoadjuvant chemotherapy in advanced gastric cancer.

Authors:  Sang Min Lee; Se Hyung Kim; Jeong Min Lee; Seock-Ah Im; Yung-Jue Bang; Woo Ho Kim; Min A Kim; Han-Kwang Yang; Hyuk-Joon Lee; Won Jun Kang; Joon Koo Han; Byung Ihn Choi
Journal:  Abdom Imaging       Date:  2009-07

Review 10.  Overall survival: a gold standard in search of a surrogate: the value of progression-free survival and time to progression as end points of drug efficacy.

Authors:  Sen H Zhuang; Liang Xiu; Yusri A Elsayed
Journal:  Cancer J       Date:  2009 Sep-Oct       Impact factor: 3.360
View more
  10 in total

1.  Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer.

Authors:  Runbi Ji; Bin Zhang; Xu Zhang; Jianguo Xue; Xiao Yuan; Yongmin Yan; Mei Wang; Wei Zhu; Hui Qian; Wenrong Xu
Journal:  Cell Cycle       Date:  2015-06-19       Impact factor: 4.534

Review 2.  Imaging strategies in the management of gastric cancer: current role and future potential of MRI.

Authors:  Alicia S Borggreve; Lucas Goense; Hylke J F Brenkman; Stella Mook; Gert J Meijer; Frank J Wessels; Marcel Verheij; Edwin P M Jansen; Richard van Hillegersberg; Peter S N van Rossum; Jelle P Ruurda
Journal:  Br J Radiol       Date:  2019-03-05       Impact factor: 3.039

3.  An application study of low-dose computed tomography perfusion imaging for evaluation of the efficacy of neoadjuvant chemotherapy for advanced gastric adenocarcinoma.

Authors:  Zongqiong Sun; Xiaofang Cheng; Yuxi Ge; Lin Shao; Yinghua Xuan; Gen Yan
Journal:  Gastric Cancer       Date:  2017-09-04       Impact factor: 7.370

4.  Gastric cancer: texture analysis from multidetector computed tomography as a potential preoperative prognostic biomarker.

Authors:  Francesco Giganti; Sofia Antunes; Annalaura Salerno; Alessandro Ambrosi; Paolo Marra; Roberto Nicoletti; Elena Orsenigo; Damiano Chiari; Luca Albarello; Carlo Staudacher; Antonio Esposito; Alessandro Del Maschio; Francesco De Cobelli
Journal:  Eur Radiol       Date:  2016-08-23       Impact factor: 5.315

5.  Predicting liver metastasis of gastrointestinal tract cancer by diffusion-weighted imaging of apparent diffusion coefficient values.

Authors:  De-Xian Zheng; Shu-Chun Meng; Qing-Jun Liu; Chuan-Ting Li; Xi-Dan Shang; Yu-Seng Zhu; Tian-Jun Bai; Shi-Ming Xu
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

6.  Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation.

Authors:  Ralf S Eschbach; Wolfgang P Fendler; Philipp M Kazmierczak; Marcus Hacker; Axel Rominger; Janette Carlsen; Heidrun Hirner-Eppeneder; Jessica Schuster; Matthias Moser; Lukas Havla; Moritz J Schneider; Michael Ingrisch; Lukas Spaeth; Maximilian F Reiser; Konstantin Nikolaou; Clemens C Cyran
Journal:  PLoS One       Date:  2015-02-10       Impact factor: 3.240

7.  Squamous cell carcinoma antigen expression in tumor cells is associated with the chemosensitivity and survival of patients with cervical cancer receiving docetaxel-carboplatin-based neoadjuvant chemotherapy.

Authors:  Peng Chen; Liang Jiao; Dan-Bo Wang
Journal:  Oncol Lett       Date:  2017-01-02       Impact factor: 2.967

8.  Gastric Cancer Maximum Tumour Diameter Reduction Rate at CT Examination as a Radiological Index for Predicting Histopathological Regression after Neoadjuvant Treatment: A Multicentre GIRCG Study.

Authors:  Maria Antonietta Mazzei; Giulio Bagnacci; Francesco Gentili; Andrea Nigri; Veronica Pelini; Carla Vindigni; Francesco Giuseppe Mazzei; Gian Luca Baiocchi; Frida Pittiani; Paolo Morgagni; Enrico Petrella; Gianni Mura; Beatrice Verdelli; Maria Bencivenga; Simone Giacopuzzi; Daniele Marrelli; Franco Roviello; Luca Volterrani
Journal:  Gastroenterol Res Pract       Date:  2018-03-15       Impact factor: 2.260

9.  Upregulation of CRABP2 by TET1-mediated DNA hydroxymethylation attenuates mitochondrial apoptosis and promotes oxaliplatin resistance in gastric cancer.

Authors:  Xiaolong Tang; Yahang Liang; Guorui Sun; Qingsi He; Zhenyu Hou; Xingzhi Jiang; Peng Gao; Hui Qu
Journal:  Cell Death Dis       Date:  2022-10-04       Impact factor: 9.685

10.  Delta-radiomics and response to neoadjuvant treatment in locally advanced gastric cancer-a multicenter study of GIRCG (Italian Research Group for Gastric Cancer).

Authors:  Maria Antonietta Mazzei; Letizia Di Giacomo; Giulio Bagnacci; Valerio Nardone; Francesco Gentili; Gabriele Lucii; Paolo Tini; Daniele Marrelli; Paolo Morgagni; Gianni Mura; Gian Luca Baiocchi; Frida Pittiani; Luca Volterrani; Franco Roviello
Journal:  Quant Imaging Med Surg       Date:  2021-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.